RANI
Rani Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.86
+1.22%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $1.3M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.05
- Revenue actual
- $1.7M
- Revenue estimate
- $925.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -28.3%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $8.50
- PT range
- $6.00 – $11
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.05 | -$0.04 | Beat 20.00% | $1.7M |
| May 15, 2026 | -$0.06 | -$0.04 | Beat 33.33% | $1.7M |
| Mar 26, 2026 | -$0.03 | -$0.07 | Miss -133.33% | $1.5M |
| Nov 6, 2025 | -$0.09 | -$0.12 | Miss -33.33% | — |
| Aug 7, 2025 | -$0.19 | -$0.18 | Beat 5.26% | — |
| Mar 31, 2025 | -$0.24 | -$0.27 | Miss -12.50% | $1.0M |
| Nov 14, 2024 | -$0.22 | -$0.24 | Miss -9.09% | — |
| Mar 20, 2024 | -$0.31 | -$0.27 | Beat 12.90% | $2.8M |
| Aug 11, 2023 | -$0.40 | -$0.37 | Beat 7.50% | — |
| Mar 22, 2023 | -$0.26 | -$0.35 | Miss -34.62% | — |
| Nov 10, 2022 | -$0.33 | -$0.33 | In line | — |
| Aug 10, 2022 | -$0.28 | -$0.31 | Miss -10.71% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026